{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:08:58Z","timestamp":1790399338528,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.addr.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T10:01:22Z","timestamp":1374400882000},"page":"131-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Encapsulated cell therapy for neurodegenerative diseases: From promise to product"],"prefix":"10.1016","volume":"67-68","author":[{"given":"Dwaine F.","family":"Emerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorka","family":"Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Tornoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars U.","family":"Wahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2013.07.008_bb0005","first-page":"203","article-title":"Blood\u2013brain barrier (BBB). Review from morphological aspect","volume":"3","author":"Cervos-Navarro","year":"1998","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.addr.2013.07.008_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","article-title":"The cell biology of the blood\u2013brain barrier","volume":"22","author":"Rubin","year":"1999","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2006.07.015","article-title":"Point source concentration of GDNF may explain failure of phase II clinical trial","volume":"202","author":"Salvatore","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3171\/JNS-07\/07\/0074","article-title":"Convective delivery of glial cell line-derived neurotrophic factor in the human putamen","volume":"107","author":"Morrison","year":"2007","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.addr.2013.07.008_bb0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s10875-007-9117-8","article-title":"Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion","volume":"27","author":"Tatarewicz","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.addr.2013.07.008_bb0035","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1523\/JNEUROSCI.22-12-04942.2002","article-title":"Lentivirally delivered glial cell-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration","volume":"22","author":"Palfi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GSNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2013.07.008_bb0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomized, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jconrel.2012.07.034","article-title":"Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases","volume":"162","author":"Huang","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.07.008_bb0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2685","article-title":"Biomaterials for promoting brain protection, repair and regeneration","volume":"10","author":"Orive","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3727\/000000004783983981","article-title":"Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum","volume":"13","author":"Emerich","year":"2004","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0065","first-page":"225","article-title":"Encapsulated cell-based delivery of Meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease","volume":"30","author":"Torn\u00f8e","year":"2012","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0070","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/gt.2011.178","article-title":"Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer","volume":"10","author":"Fjord-Larsen","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0075","first-page":"265","article-title":"Immunoisolation cell therapy for CNS diseases","volume":"18","author":"Emerich","year":"2001","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2013.07.008_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF03261887","article-title":"A perspective on bioactive cell microencapsulation","volume":"26","author":"Acarregui","year":"2012","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2013.07.008_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.8420006","article-title":"Blood\u2013brain barrier penetration and in vivo activity of an NGF conjugate","volume":"259","author":"Friden","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.addr.2013.07.008_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1227\/00006123-199408000-00016","article-title":"Receptor-mediated transport of therapeutics across the blood\u2013brain barrier","volume":"35","author":"Friden","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1016\/j.addr.2013.07.008_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(96)13265-1","article-title":"Enhanced delivery of [125I] glial cell line-derived neurotrophic factor to the rat CNS following osmotic blood\u2013brain barrier modification","volume":"220","author":"Jiao","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.addr.2013.07.008_bb0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the blood\u2013brain barrier for therapeutic purposes: osmotic opening and other means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.addr.2013.07.008_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.1993.1105","article-title":"Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats","volume":"122","author":"Emerich","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0006-8993(96)00683-X","article-title":"Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts","volume":"736","author":"Emerich","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/exnr.2000.7311","article-title":"Mammalian-cell-produced neurturin (NTN) is more potent than purified Escherichia","volume":"162","author":"Hoane","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0963-6897(96)00081-4","article-title":"Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF","volume":"5","author":"Tan","year":"1996","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0963-6897(95)02029-2","article-title":"Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats","volume":"5","author":"Lindner","year":"1996","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0306-4522(95)00543-9","article-title":"Intrastriatal implants of polymer-encapsulated cells genetically modified to secrete human NGF: trophic effects upon cholinergic and noncholinergic neurons","volume":"72","author":"Kordower","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.addr.2013.07.008_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cne.903490110","article-title":"Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons","volume":"349","author":"Emerich","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0140","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1073\/pnas.91.6.2324","article-title":"Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons","volume":"91","author":"Winn","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2013.07.008_bb0145","doi-asserted-by":"crossref","first-page":"10898","DOI":"10.1073\/pnas.91.23.10898","article-title":"The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor","volume":"91","author":"Kordower","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2013.07.008_bb0150","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1523\/JNEUROSCI.4182-09.2010","article-title":"Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease","volume":"30","author":"Garcia","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0155","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","article-title":"The effect of encapsulated VEGF-secreting cells on brain amyloid and behavioral impairment in a mouse model of Alzheimer's disease","volume":"31","author":"Spuch","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.07.008_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.brainres.2010.10.054","article-title":"BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats","volume":"11368","author":"Kuramoto","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.expneurol.2008.12.021","article-title":"GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus","volume":"216","author":"Kanter-Schlifke","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/exnr.1994.1193","article-title":"Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum","volume":"130","author":"Emerich","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0175","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1523\/JNEUROSCI.16-16-05168.1996","article-title":"Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease","volume":"1","author":"Emerich","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0963-6897(97)00035-3","article-title":"Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease","volume":"6","author":"Emerich","year":"1997","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0185","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/386395a0","article-title":"Protective effects of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease","volume":"386","author":"Emerich","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.addr.2013.07.008_bb0190","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/10430340050015220","article-title":"Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington's disease","volume":"11","author":"Mittoux","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1999.7156","article-title":"Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?","volume":"59","author":"Kordower","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0200","first-page":"581","article-title":"Encapsulated CNTF-producing cells for Huntington's disease","volume":"581","author":"Emerich","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0205","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3727\/000000007783472426","article-title":"Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease","volume":"16","author":"Borlongan","year":"2008","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0210","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/00001756-200411150-00018","article-title":"Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease","volume":"15","author":"Borlongan","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.addr.2013.07.008_bb0215","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3727\/000000007783465145","article-title":"Aging reduces the neuroprotective capacity, VEGF secretion, and metabolic activity of rat choroid plexus epithelial cells","volume":"16","author":"Emerich","year":"2007","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3727\/000000007783464867","article-title":"In vitro exposure of cultured porcine choroid plexus epithelial cells to immunosuppressant, anti-inflammatory, and psychoactive drugs","volume":"16","author":"Emerich","year":"2007","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3727\/000000006783981657","article-title":"In vitro culture duration does not impact the ability of encapsulated choroid plexus transplants to prevent neurological deficits in an excitotoxin-lesioned rat model of Huntington's disease","volume":"15","author":"Emerich","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0230","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nbd.2006.04.014","article-title":"Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys","volume":"23","author":"Emerich","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.addr.2013.07.008_bb0235","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0014-4886(91)90022-5","article-title":"Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells","volume":"113","author":"Winn","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(91)91212-J","article-title":"Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats","volume":"560","author":"Aebischer","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002480-199201000-00006","article-title":"Polymer encapsulated neurotransmitter secreting cells: potential treatment for Parkinson's disease","volume":"38","author":"Tresco","year":"1992","journal-title":"ASAIO"},{"key":"10.1016\/j.addr.2013.07.008_bb0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0963689792001002-307","article-title":"Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesioned-induced rotational behavior","volume":"1","author":"Tresco","year":"1992","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/096368979300200308","article-title":"Transplantation of polymer encapsulated PC12 cells: use of chitosan as an immobilization matrix","volume":"2","author":"Emerich","year":"1993","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.1994.1053","article-title":"Functional recovery in hemiparkinsonian primates transplanted with polymer encapsulated PC12 cells","volume":"126","author":"Aebischer","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0963-6897(97)00169-3","article-title":"Therapeutic potential of a polymer-encapsulated l-DOPA and dopamine-producing cell line in rodent and primate models of Parkinsons disease","volume":"7","author":"Lindner","year":"1998","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0963-6897(95)90031-4","article-title":"Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical and neurochemical analysis","volume":"4","author":"Kordower","year":"1995","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0963-6897(97)00049-3","article-title":"Polymer-encapsulated PC12 cells demonstrate high affinity uptake of dopamine in vitro and 18F-dopa uptake and metabolism after intracerebral implantation in nonhuman primate","volume":"6","author":"Subramanian","year":"1997","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0280","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0278-5846(94)90109-0","article-title":"Intrastriatal implants of polymer-encapsulated PC12 cells: effects on motor function in aged rats","volume":"18","author":"Emerich","year":"1994","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.addr.2013.07.008_bb0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0963-6897(96)00086-3","article-title":"Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rats","volume":"5","author":"Emerich","year":"1997","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/exnr.1997.6456","article-title":"Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window or oral Sinemet in rats","volume":"14","author":"Lindner","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.1999.7175","article-title":"Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor","volume":"160","author":"Hoane","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/exnr.2000.7311","article-title":"Mammalian-cell-produced Neurturin (NTN) is more potent that purified Escherichia coli-produced NTN","volume":"162","author":"Hoane","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1523\/JNEUROSCI.17-01-00325.1997","article-title":"GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine","volume":"1","author":"Tseng","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0310","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/00001756-199806010-00027","article-title":"Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy","volume":"9","author":"Tseng","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.addr.2013.07.008_bb0315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2007.08.019","article-title":"Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?","volume":"209","author":"Lindvall","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2217\/rme.11.15","article-title":"Restoration of motor control and dopaminergic activity in rats with unilateral 6-hydroxydopamine lesions","volume":"6","author":"Skinner","year":"2011","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2013.07.008_bb0325","first-page":"3292","article-title":"Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa","volume":"43","author":"Tao","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2013.07.008_bb0330","doi-asserted-by":"crossref","first-page":"138:156","DOI":"10.1089\/neu.2005.22.138","article-title":"Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression","volume":"22","author":"Tobias","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.addr.2013.07.008_bb0335","first-page":"137","article-title":"Cell therapy using encapsulated cells producing endostatin","volume":"88","author":"Bjerkvig","year":"2003","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.addr.2013.07.008_bb0340","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/000000003108746902","article-title":"Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin","volume":"12","author":"Rokstad","year":"2003","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0345","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14712598.3.4.551","article-title":"Progress and challenges for cell encapsulation in brain tumor therapy","volume":"3","author":"Visted","year":"2003","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0350","first-page":"10:19","article-title":"Anti-tumor therapy with macroencapsulated endostatin producer cells","volume":"2","author":"Rodrigues","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.addr.2013.07.008_bb0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-005-9071-3","article-title":"The efficacy of alginate encapsulated CHO-K1 single chain-TRAIL producer cells in the treatment of brain tumors","volume":"78","author":"Kuijlen","year":"2006","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.addr.2013.07.008_bb0360","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/104303402320138943","article-title":"A novel approach to tumor suppression with microencapsulated recombinant cells","volume":"13","author":"Cirone","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/83481","article-title":"Continuous release of endostatin from microencapsulated engineered cells for tumor therapy","volume":"19","author":"Joki","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2013.07.008_bb0370","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2249.1995.tb03839.x","article-title":"Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth","volume":"102","author":"Lang","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2013.07.008_bb0375","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/ejso.2002.1386","article-title":"Encapsulation of packaging cell results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma","volume":"29","author":"Martnet","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.addr.2013.07.008_bb0380","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/83471","article-title":"Local endostatin treatment of gliomas administered by microencapsulated producer cells","volume":"19","author":"Read","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2013.07.008_bb0385","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/096368970000900604","article-title":"Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors","volume":"9","author":"Thorsen","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1096\/fj.01-0590fje","article-title":"Microencapsulated iNOS-expressing cells cause tumor suppression in mice","volume":"16","author":"Xu","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2013.07.008_bb0395","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0301-0082(95)00011-J","article-title":"Update on cellular transplantation into the rat CNS as a novel therapy for chronic pain","volume":"46","author":"Czech","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.addr.2013.07.008_bb0400","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1054-3589(08)60817-0","article-title":"Cellular transplantation for intractable pain","volume":"42","author":"Sagen","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.addr.2013.07.008_bb0405","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4097\/kjae.2011.60.5.357","article-title":"Cultured human chromaffin cells grafted in spinal subarachnoid space relieves allodynia in a pain rat model","volume":"60","author":"Jeon","year":"2011","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.addr.2013.07.008_bb0410","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.transproceed.2006.08.098","article-title":"Intrathecal implants of microencapsulated xenogenic chromaffin cells provide a long-term source of analgesic substances","volume":"38","author":"Jeon","year":"2006","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.addr.2013.07.008_bb0415","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm0696-696","article-title":"Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients","volume":"2","author":"Aebischer","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2013.07.008_bb0420","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/096368970000900404","article-title":"Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically-engineered xenogeneic cells","volume":"9","author":"Zurn","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2013.07.008_bb0425","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3171\/2012.2.JNS11714","article-title":"Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery","volume":"117","author":"Wahlberg","year":"2012","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.addr.2013.07.008_bb0430","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000336051","article-title":"Encapsulated cell biodelivery of nerve growth factor to the basal forebrain in patients with Alzheimer's disease","volume":"33","author":"Eriksdotter-J\u00f6nhagen","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.addr.2013.07.008_bb0435","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00007890-199412150-00025","article-title":"Transplantation in humans of encapsulated xenogeneic cells without immunosuppression\u2014a preliminary report","volume":"58","author":"Aebischer","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2013.07.008_bb0440","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00000542-199611000-00007","article-title":"Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience","volume":"85","author":"Buschser","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.addr.2013.07.008_bb0445","series-title":"CytoTherapeutics press release, Providence, RI","year":"1999"},{"key":"10.1016\/j.addr.2013.07.008_bb0450","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1089\/10430340050111377","article-title":"Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF","volume":"11","author":"Bachoud-Levi","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0455","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2013.07.008_bb0460","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1167\/iovs.12-9970","article-title":"Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases","volume":"53","author":"Kauper","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2013.07.008_bb0465","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0142-9612(96)85563-3","article-title":"Transport characterization of membranes for immunoisolation","volume":"17","author":"Dionne","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.07.008_bb0470","series-title":"Methods in Neuroscience","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/B978-0-12-185291-7.50029-1","article-title":"Hydrogel applications for encapsulated cellular transplants","volume":"vol. 21","author":"Winn","year":"1994"},{"key":"10.1016\/j.addr.2013.07.008_bb0475","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-4886(91)90093-R","article-title":"Long-term cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell lines","volume":"111","author":"Aebischer","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0480","first-page":"21","article-title":"Intraventricular encapsulated bovine adrenal chromaffin cells: viable for at least 500days in vivo without detectable host immune sensitization or adverse effects on behavioral\/cognitive function","volume":"11","author":"Lindner","year":"1997","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0485","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1523\/JNEUROSCI.13-06-02415.1993","article-title":"Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances","volume":"13","author":"Sagen","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0490","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/exnr.1997.6579","article-title":"Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells","volume":"147","author":"Date","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0495","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/exnr.1996.0123","article-title":"Polymer-encapsulated genetically-modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences","volume":"140","author":"Winn","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0500","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1460-9568.2005.04414.x","article-title":"Lentivector-mediated delivery of GDNF protects complex motor fucntions relevant to human Parkinsonism in a rat lesion model","volume":"22","author":"Dowd","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0505","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molbrainres.2004.06.029","article-title":"Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease","volume":"134","author":"Zheng","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0510","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.addr.2013.07.008_bb0515","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1523\/JNEUROSCI.22-12-04942.2002","article-title":"Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration","volume":"22","author":"Palfi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0520","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2013.07.008_bb0525","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q","article-title":"Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease","volume":"46","author":"Kordower","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0530","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputaminal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2013.07.008_bb0535","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2013.07.008_bb0540","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.20861","article-title":"Crossroads in GDNF therapy for Parkinson's disease","volume":"21","author":"Sherer","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.addr.2013.07.008_bb0545","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3171\/JNS-07\/07\/0074","article-title":"Convective delivery of glial cell line-derived neurotrophic factor in the human putamen","volume":"107","author":"Morrison","year":"2007","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.addr.2013.07.008_bb0550","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.nbd.2004.03.012","article-title":"Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons","volume":"16","author":"Kishima","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.addr.2013.07.008_bb0555","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2007.05.027","article-title":"Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats","volume":"343","author":"Grandoso","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2013.07.008_bb0560","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/jnr.10375","article-title":"Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease","volume":"69","author":"Shingo","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0565","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3171\/jns.2005.102.1.0080","article-title":"Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease","volume":"102","author":"Yasuhara","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.addr.2013.07.008_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.12.055","article-title":"The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model","volume":"1038","author":"Yasuhara","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0575","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.05.027","article-title":"Neurorescue effects of VEGF on a rat model of Parkinson's disease","volume":"1053","author":"Yasuhara","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0580","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1460-9568.2004.03254.x","article-title":"Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease","volume":"19","author":"Yasuhara","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.addr.2013.07.008_bb0585","doi-asserted-by":"crossref","first-page":"065001","DOI":"10.1088\/1741-2560\/6\/6\/065001","article-title":"Encapsulated living choroid plexus cells: potential long-term treatments for central nervous system disease and trauma","volume":"6","author":"Skinner","year":"2009","journal-title":"J. Neural Eng."},{"key":"10.1016\/j.addr.2013.07.008_bb0590","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3171\/jns.1996.84.6.1006","article-title":"Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats","volume":"84","author":"Date","year":"1996","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.addr.2013.07.008_bb0595","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/00001756-199607290-00025","article-title":"Chromaffin cell survival from both young and old donors is enhanced by co-grafts of polymer-encapsulated human NGF-secreting cells","volume":"7","author":"Date","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.addr.2013.07.008_bb0600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresbull.2005.04.009","article-title":"Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor","volume":"66","author":"Ahn","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.addr.2013.07.008_bb0610","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2002-4605","article-title":"The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease","volume":"4","author":"Perry","year":"2002","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2013.07.008_bb0615","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.10611","article-title":"Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron","volume":"72","author":"Perry","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.addr.2013.07.008_bb0620","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0625","first-page":"6","article-title":"Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic","volume":"497","author":"Klinge","year":"2011","journal-title":"Letters"},{"key":"10.1016\/j.addr.2013.07.008_bb0630","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","article-title":"The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease","volume":"31","author":"Spuch","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.07.008_bb0635","first-page":"1","article-title":"Encapsulated VEGF-secreting cells enhance proliferation of neuronal progenitors in the hippocampus of APP\/Ps1 mice","volume":"30","author":"Antequera","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2013.07.008_bb0640","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/gt.2011.178","article-title":"Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer","volume":"19","author":"Fjord-Larsen","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0645","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/mt.2010.154","article-title":"Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Gottingen minipig basal forebrain","volume":"18","author":"Fjord-Larsen","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2013.07.008_bb0650","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1875043501205010035","article-title":"Encapsulated cell biodelivery of transposon-mediated high dose NGF to the Gottingen minipig basal forebrain","volume":"5","author":"Fjord-Larsen","year":"2012","journal-title":"Open Tissue Eng. Regen. Med. J."},{"key":"10.1016\/j.addr.2013.07.008_bb0655","series-title":"Complete Protection of Dopaminergic Neurons Following Encapsulated Cell Biodelivery of GDNF in 6-OHDA-lesioned Rats","author":"Emerich","year":"2013"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X13001622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X13001622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:34:00Z","timestamp":1563496440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X13001622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":130,"alternative-id":["S0169409X13001622"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2013.07.008","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Encapsulated cell therapy for neurodegenerative diseases: From promise to product","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}